Search results
Results From The WOW.Com Content Network
Ted Kaptchuk in an NCCIH interview about the use of placebos in research. Ted Jack Kaptchuk (born August 17, 1947) is an American medical researcher who holds professorships in medicine and in global health and social medicine at Harvard Medical School. He researches the placebo effect within the field of placebo studies.
Myanmar Medical Journal: Medicine: Myanmar Medical Association: English: 1953–present Nano Biomedicine and Engineering: Medicine: Open-Access House of Science and Technology: English: 2009–present National Medical Journal of India: Medicine: All India Institute of Medical Sciences, New Delhi: English: 1988–present Nature Medicine ...
Harvard Medical School (HMS) is the medical school of Harvard University and is located in the Longwood Medical Area in Boston, Massachusetts.Founded in 1782, HMS is one of the oldest medical schools in the United States, [2] and provides patient care, medical education, and research training through its 15 clinical affiliates and research institutes, including Massachusetts General Hospital ...
According to the History of Medicine Division of the National Institutes of Health's National Library of Medicine, The Francis A. Countway Library of Medicine is the "largest academic medical library in the world, and its collections, which have been formed over nearly two centuries, sometimes through the medical holdings of other libraries ...
Richard Smith, the former editor of the medical journal the BMJ, has been critical of many of the aspects of modern-day medical journal publishing. [5] [12] Critics of medical publishing have argued that problems related to gaming of citation and authorship are prevalent in the field, as many authors did not actually contribute to the articles that their names are on, many contributors to the ...
Martin Kulldorff (born 1962) is a Swedish biostatistician.He was a professor of medicine at Harvard Medical School from 2003 until his dismissal in 2024. [2] [3] [4] He is a member of the US Food and Drug Administration's Drug Safety and Risk Management Advisory Committee and a former member of the Vaccine Safety Subgroup of the Advisory Committee on Immunization Practices at the Centers for ...
The research was published in Science Translational Medicine in 2021 and showed the possibility of a less immunogenic gene therapy with the new TLR9-edited Adeno-associated viruses (AAV) as a safer viral vector. [72] Based on the research, Church and a postdoc from his lab who was also the first-author of the research, co-founded Ally Therapeutics.
When then-EPA director, Scott Pruitt, announced his proposed scientific research policy requiring full transparency of all studies that inform public environmental policies, this would have excluded studies, such as the Six Cities studies, because they used confidential data in personal medical reports that could not be made openly available. [22]